The aim of this review is to discuss the emerging role of DDR alterations in the pathophysiology of two chronic myeloproliferative disease states, BCR-ABL-positive CML and JAK2 V617F-positive PV. This evidence concerns the gene ABL1 and myeloproliferative neoplasm.